Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL668320 | 0.82 | SLC6A4 (0.33) | LIPG | |
| Hydrochloric Acid SCHEMBL9274789 | 0.81 | TSHR (0.36) | — | |
| SCHEMBL3229542 | 0.81 | ALDH1A1 (0.33) | LIPG | |
| SCHEMBL830877 | 0.80 | NR3C1 (0.31) | — | |
| SCHEMBL829803 | 0.80 | MEN1 (0.30) | — | |
| SCHEMBL829740 | 0.80 | — | — | |
| SCHEMBL5952272 | 0.79 | ENPP2 (0.32) | ENPP2 | |
| SCHEMBL14645439 | 0.79 | KDM4E (0.37) | — | |
| SCHEMBL5899432 | 0.78 | TSHR (0.36) | ENPP2 | |
| SCHEMBL829759 | 0.77 | PDE2A (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025021960-A1 | BIOSENSORS FOR MEASURING GLUCOSE CONCENTRATION AND GLUCOSE-SENSING POLYMERS | GLUCOSET AS (NO) | 2025-01-30 | — | — | WO | disclosed |
| CN-117740746-A | Method for detecting benzoyl peroxide based on sensitized luminous hydrogel | 河南省科学院化学研究所有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-112480025-B | Compound with aggregation-induced emission function and preparation method and application thereof | 汉中职业技术学院 | 2022-07-12 | — | — | CN | disclosed |
| CN-112480025-A | Compound with aggregation-induced emission function and preparation method and application thereof | 汉中职业技术学院 | 2021-03-12 | — | — | CN | disclosed |
| US-20170059573-A1 | METHOD OF DETECTING PEROXYNITRITE USING A COMPLEX OF A SACCHARIDE AND AN ARYLBORONATE-BASED FLUORESCENT PROBE | UNIVERSITY OF BATH (GB) | 2017-03-02 | — | — | US | disclosed |
| EP-3110827-A1 | METHOD OF DETECTING PEROXYNITRITE USING A COMPLEX OF A SACCHARIDE AND AN ARYLBORONATE-BASED! FLUORESCENT PROBE | University of Bath (GB) | 2017-01-04 | — | — | EP | disclosed |
| EP-3053914-A1 | FLUOROPHORE AND FLUORESCENT SENSOR COMPOUND CONTAINING SAME | LIGHTSHIP MEDICAL LIMITED (GB) | 2016-08-10 | — | — | EP | disclosed |
| US-9382280-B2 | Diamine compound and metal complexes, and method for producing optically active compounds | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2016-07-05 | — | — | US | disclosed |
| EP-2417102-B1 | FLUOROPHORE AND FLUORESCENT SENSOR COMPOUND CONTAINING SAME | LIGHTSHIP MEDICAL LTD (GB) | 2016-04-06 | — | — | EP | disclosed |
| US-20160033521-A1 | FLUOROPHORE AND FLUORESCENT SENSOR COMPOUND CONTAINING SAME | LIGHTSHIP MEDICAL LIMITED (GB) | 2016-02-04 | — | — | US | disclosed |
| EP-1490359-A4 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MED & SCIENCE INC (US) | 2006-08-23 | — | — | EP | disclosed |
| US-7078554-B2 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2006-07-18 | — | — | US | disclosed |
| US-20050043275-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSEONICS, INCORPORATED | 2005-02-24 | — | — | US | disclosed |
| EP-1490359-A1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | Sensors for Medicine and Science, Inc. (US) | 2004-12-29 | — | — | EP | disclosed |
| US-20040235792-A1 | Serine protease inhibitors compromising a hydrogen-bond acceptor | TRIGEN LIMITED (GB) | 2004-11-25 | — | — | US | disclosed |
| US-6800451-B2 | MORE STABLE REACTION OF GLUCOSE WITH A BORONIC ACID COMPOUND SUCH AS 9,10-BISN-(BORONOBENZYL)-N-(3-(METHYACRYLAMIDO) PROPYLAMINO)METHYLANTHRACENE | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2004-10-05 | — | — | US | disclosed |
| WO-2003078424-A1 | DETECTION OF GLUCOSE IN SOLUTIONS ALSO CONTAINING AN ALPHA-HYDROXY ACID OR A BETA-DIKETONE | SENSORS FOR MEDICINE AND SCIENCE, INC. (US) | 2003-09-25 | — | — | WO | disclosed |
| US-20030082663-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | SENSORS FOR MEDICINE AND SCIENCE, INC. | 2003-05-01 | — | — | US | disclosed |
| WO-2002057273-A9 | SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR | TRIGEN LTD (GB) | 2002-11-28 | — | — | WO | disclosed |
| WO-2002057273-A1 | SERINE PROTEASE INHIBITORS COMPRISING A HYDROGEN-BOND ACCEPTOR | TRIGEN LIMITED (GB) | 2002-07-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043275-A1 | Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone | GCK, KHK, HK1 | LIPG 2093/4885ENPP2 3870/4885 |
| US-20170059573-A1 | METHOD OF DETECTING PEROXYNITRITE USING A COMPLEX OF A SACCHARIDE AND AN ARYLBORONATE-BASED FLUORESCENT PROBE | AOX1, FBP1, CYBB | LIPG 1668/4885ENPP2 894/4885 |
| US-20040235792-A1 | Serine protease inhibitors compromising a hydrogen-bond acceptor | SERPINB1, SPINT2, CTRL | LIPG 1799/4885ENPP2 1293/4885 |
| US-20160033521-A1 | FLUOROPHORE AND FLUORESCENT SENSOR COMPOUND CONTAINING SAME | QRFPR, TRPA1, GPR52 | LIPG 3357/4885ENPP2 2199/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.